Comparison of early clinical outcomes between dual antiplatelet therapy and triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
Jiesuck ParkJin- Hyung JungEue-Keun ChoiSeung-Woo LeeSoonil KwonSo-Ryoung LeeJeehoon KangKyung-Do HanKyung Woo ParkSeil OhGregory Yoke Hong LipPublished in: PloS one (2022)
An outcome benefit of DAPT was observed in the early period after PCI compared to the VKA-TT, but not against NOAC-TT users among the Asian AF population. Given the potential long-term benefits of NOACs, greater efforts should be made to increase compliance in clinical practice with proper combination therapy with NOAC after PCI.
Keyphrases
- antiplatelet therapy
- percutaneous coronary intervention
- atrial fibrillation
- combination therapy
- oral anticoagulants
- acute coronary syndrome
- st segment elevation myocardial infarction
- acute myocardial infarction
- st elevation myocardial infarction
- coronary artery disease
- coronary artery bypass grafting
- clinical practice
- heart failure
- stem cells
- quality improvement
- bone marrow